Clinical Trial Details
EORTC-20884-LYMG
Back to Clinical Trials Database
Prospective randomized controlled trial of adjuvant involved field radiotherapy after MOPP/ABV hybrid chemotherapy in advanced Hodgkin disease. H34 Trial
| Trial Status | LT-FU ongoing |
|---|---|
| Dates |
Date of activation: 15-Sep-1989 Date Step1 close: 01-May-2000 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 615 |
| Treatment |
Radiotherapy, Drug |
| Study Staff | Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels |
| Type of cancer | Hodgkins Disease |
| Participating groups |
EORTC Lymphoma Group Pierre et Marie Curie Group |
| Protocol summary | http://clinicaltrials.gov/study/NCT00002462 |
| NCT number | NCT00002462 |
| Financial Support | Academic Fund |
